The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain
CLOSE-GAP
The Clinical Effects of Intracorporally Closure of the Hernia Defect in Laparoscopic Umbilical or Epigastric Hernia Repair
1 other identifier
interventional
80
1 country
1
Brief Summary
Introduction: Closure of the hernia gap in laparoscopic ventral hernia repair before mesh reinforcement has gained increasing acceptance among surgeons despite creating a tension-based repair. Beneficial effects of this technique have sporadically been reported but no evidence is available from randomized controlled trials. The primary purpose is to compare early postoperative activity-related pain in patients undergoing ventral hernia repair with closure of the gap with patients undergoing standard laparoscopic ventral hernia repair (non-closure of the gap). Secondary outcomes are cosmesis and hernia-related quality of life (QoL) at 30-days and clinical or radiological recurrence and chronic pain after 2 years. Material and Methods: A randomized, controlled, double-blinded study is planned. Based on power calculation we will include 40 patients in each arm. Patients undergoing elective laparoscopic umbilical, epigastric, or umbilical trocar-site hernia repair at Hvidovre Hospital, Herlev Hospital, or Køge Hospital, who meet the inclusion criteria, are invited to participate. Conclusion: The technique with closure of the gap may induce more postoperative pain, but may be superior with regard to other important surgical outcomes. No studies have previously investigated closure of the gap in the setting of a randomised controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2013
CompletedFirst Posted
Study publicly available on registry
October 14, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedFebruary 22, 2019
February 1, 2019
2.8 years
October 7, 2013
February 21, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Pain at mobilisation from lying to sitting position measured with Visual Analogue Scale
24 hrs postoperatively
Secondary Outcomes (1)
Cosmetic result measured with verbal rating scale and numeric rating scales
measured 30 days postoperatively
Other Outcomes (4)
Hernia-specific quality of life
measured 30 days postoperatively
complications, readmittance, and general practitioner visits
30-days postoperatively
clinical recurrence
2 years
- +1 more other outcomes
Study Arms (2)
sutured closure of the hernia gap
ACTIVE COMPARATORThe hernia gap is sutured intracorporally
No closure of the hernia gap
NO INTERVENTIONPhysiomesh is placed with at least 5 cm overlap of the gap and fixated with double crown technique
Interventions
The hernia gab is closed with non-absorbable suture (Ethibond Excel 2-0, Ethicon, Johnson \& Johnson©) performed by an intracorporally interrupted sutured technique using an Auto Suture© Endo-Slide knot-tying instrument. The stitches are placed with a distance of 0.5 - 1 cm from the fascial edges and with a distance of 0.5-1 cm. between the stitches, performed under a 6-8 mmHg intrabdominal pressure.
Eligibility Criteria
You may qualify if:
- Elective, primary or recurrent laparoscopic umbilical or epigastric hernia repair, umbilical trocar-site hernia and epigastric hernia repair where laparoscopic hernia repair is no contraindication (i.e. previous laparotomy with anticipated severe and dense adhesions
- Hernia defect between 2-6 cm measured preoperatively by the surgeon at the out-patient clinic
- Maximum 1 defect
- Patients 18-80 years Patients with technical failure (where it is not possible to suture the defect) or patients who are reoperated due to complications remain included and will stay in their primary assigned randomization group in order to perform an intention to treat (ITT) analysis.
You may not qualify if:
- Open hernia repair
- Poor compliance (language problems, dementia and alcohol or drug abuse etc.)
- Fascia defect \>6 cm (largest diameter, evaluated preoperatively and intra-operatively, thus patients are excluded if the defect is found larger intra-operatively)
- Emergency repair
- Chronic pain syndrome (chronic back pain, chronic headache, severe dysmenorrhea, fibromyalgia, whiplash or other conditions requiring daily opioid medication)
- Daily consumption of opioids (for the last 3 weeks up till the operation)
- Decompensated liver cirrhosis (Child-Pugh B-C)
- If the hernia repair is secondarily to another surgical procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hvidovre University Hospitallead
- University of Copenhagencollaborator
Study Sites (1)
Hvidovre University Hospital
Hvidovre, 2650, Denmark
Related Publications (3)
Sauerland S, Walgenbach M, Habermalz B, Seiler CM, Miserez M. Laparoscopic versus open surgical techniques for ventral or incisional hernia repair. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007781. doi: 10.1002/14651858.CD007781.pub2.
PMID: 21412910BACKGROUNDChristoffersen MW, Westen M, Rosenberg J, Helgstrand F, Bisgaard T. Closure of the fascial defect during laparoscopic umbilical hernia repair: a randomized clinical trial. Br J Surg. 2020 Feb;107(3):200-208. doi: 10.1002/bjs.11490.
PMID: 31971616DERIVEDChristoffersen MW, Westen M, Assadzadeh S, Deigaard SL, Rosenberg J, Bisgaard T. The clinical effects of closure of the hernia gap after laparoscopic ventral hernia repair: protocol for a randomised controlled trial. Dan Med J. 2014 Jun;61(6):A4865.
PMID: 24947633DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mette Christoffersen, M.D.
Individual Purchaser
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D, PhD
Study Record Dates
First Submitted
October 7, 2013
First Posted
October 14, 2013
Study Start
November 1, 2013
Primary Completion
August 1, 2016
Study Completion
February 1, 2019
Last Updated
February 22, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share